News and Views
Nature Medicine 14, 249 - 250 (2008)
doi:10.1038/nm0308-249
Reducing glutamate signaling pays off in fragile X
Gary J Bassell1 & Christina Gross1
- Gary J. Bassell is associate professor in the Departments of Cell Biology and Neurology and Christina Gross is postdoctoral fellow in the Department of Cell Biology, Whitehead Biomedical Research Building #415, Emory University School of Medicine, 615 Michael Street, Atlanta, Georgia 30322, USA. e-mail: gbassel@emory.edu
Abstract
A recent theory about the basis for fragile X syndrome is now validated in a mouse model. The findings point the way to treatment options targeting group 1 metabotropic glutamate receptors.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stabilityNature Neuroscience Article (01 May 2007)
Identification of small molecules rescuing fragile X syndrome phenotypes in DrosophilaNature Chemical Biology Article (01 Apr 2008)
